1. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition
   Pingde Zhang et al, 2017, J Neurooncol CrossRef
2. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells
   Jian Ma et al, 2016 CrossRef
3. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
   Sabine Hombach-Klonisch et al, 2018, Pharmacol Ther CrossRef
4. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway
   Hao Xue et al, 2016, Autophagy CrossRef
5. Editing Cytoprotective Autophagy in Glioma: An Unfulfilled Potential for Therapy
   Ilya Ulasov et al, 2019, Trends in Molecular Medicine CrossRef
6. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
   Yong Zheng et al, 2021, Cell Biosci CrossRef
7. Comprehensive pharmacogenomics characterization of temozolomide response in gliomas
   Shuangmei Tong et al, 2021, European Journal of Pharmacology CrossRef
8. Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?
   Ahmed M. Elshazly et al, 2023, Cells CrossRef
9. Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma
   Magdalena Kusaczuk et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
10. null
    Nadia M. Hamdy et al, 2024 CrossRef